News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
721,189 Results
Type
Article (40897)
Company Profile (267)
Press Release (680015)
Multimedia
Podcasts (80)
Webinars (17)
Section
Business (204665)
Career Advice (2022)
Deals (35531)
Drug Delivery (110)
Drug Development (81370)
Employer Resources (173)
FDA (16403)
Job Trends (14942)
News (346366)
Policy (32727)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2566)
Accelerated approval (31)
Adcomms (24)
Allergies (137)
Alliances (49586)
ALS (168)
Alzheimer's disease (1660)
Antibody-drug conjugate (ADC) (305)
Approvals (16668)
Artificial intelligence (501)
Autoimmune disease (144)
Automation (37)
Bankruptcy (361)
Best Places to Work (11637)
BIOSECURE Act (20)
Biosimilars (187)
Biotechnology (174)
Bladder cancer (157)
Brain cancer (55)
Breast cancer (632)
Cancer (4752)
Cardiovascular disease (395)
Career advice (1707)
Career pathing (35)
CAR-T (275)
CDC (44)
Celiac Disease (2)
Cell therapy (729)
Cervical cancer (36)
Clinical research (69491)
Collaboration (1667)
Company closure (4)
Compensation (1146)
Complete response letters (52)
COVID-19 (2707)
CRISPR (87)
C-suite (811)
Cystic fibrosis (143)
Data (6154)
Decentralized trials (2)
Denatured (25)
Depression (130)
Diabetes (495)
Diagnostics (6670)
Digital health (44)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (242)
Drug pricing (184)
Drug shortages (28)
Duchenne muscular dystrophy (227)
Earnings (90037)
Editorial (55)
Employer branding (21)
Employer resources (151)
Events (117187)
Executive appointments (958)
FDA (19481)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (23)
Funding (1445)
Gene editing (191)
Generative AI (42)
Gene therapy (582)
GLP-1 (962)
Government (4652)
Grass and pollen (6)
Guidances (383)
Healthcare (18868)
HIV (55)
Huntington's disease (44)
IgA nephropathy (81)
Immunology and inflammation (244)
Immuno-oncology (53)
Indications (104)
Infectious disease (2965)
Inflammatory bowel disease (187)
Inflation Reduction Act (14)
Influenza (110)
Intellectual property (242)
Interviews (315)
IPO (16638)
IRA (49)
Job creations (3641)
Job search strategy (1427)
JPM (56)
Kidney cancer (15)
Labor market (83)
Layoffs (545)
Leadership (30)
Legal (7948)
Liver cancer (91)
Longevity (14)
Lung cancer (639)
Lymphoma (372)
Machine learning (42)
Management (59)
Manufacturing (777)
MASH (161)
Medical device (13757)
Medtech (13809)
Mergers & acquisitions (19950)
Metabolic disorders (1251)
Multiple sclerosis (159)
NASH (16)
Neurodegenerative disease (308)
Neuropsychiatric disorders (86)
Neuroscience (2871)
Neurotech (1)
NextGen: Class of 2026 (6519)
Non-profit (4510)
Now hiring (65)
Obesity (587)
Opinion (257)
Ovarian cancer (164)
Pain (197)
Pancreatic cancer (222)
Parkinson's disease (279)
Partnered (33)
Patents (487)
Patient recruitment (471)
Peanut (55)
People (58809)
Pharmaceutical (62)
Pharmacy benefit managers (29)
Phase 1 (21665)
Phase 2 (30584)
Phase 3 (22790)
Pipeline (5098)
Policy (278)
Postmarket research (2564)
Preclinical (9190)
Press Release (64)
Prostate cancer (234)
Psychedelics (47)
Radiopharmaceuticals (277)
Rare diseases (814)
Real estate (5954)
Recruiting (69)
Regulatory (24423)
Reports (51)
Research institute (2383)
Resumes & cover letters (351)
Rett syndrome (27)
RNA editing (16)
RSV (76)
Schizophrenia (146)
Series A (237)
Series B (185)
Service/supplier (11)
Sickle cell disease (95)
Special edition (21)
Spinal muscular atrophy (157)
Sponsored (41)
Startups (3612)
State (2)
Stomach cancer (17)
Supply chain (104)
Tariffs (84)
The Weekly (53)
Vaccines (983)
Venture capital (86)
Weight loss (377)
Women's health (87)
Worklife (18)
Date
Today (50)
Last 7 days (591)
Last 30 days (1989)
Last 365 days (29772)
2026 (2861)
2025 (30172)
2024 (35215)
2023 (40075)
2022 (51174)
2021 (55711)
2020 (54084)
2019 (46543)
2018 (35021)
2017 (32110)
2016 (31482)
2015 (37554)
2014 (31321)
2013 (26350)
2012 (28573)
2011 (29265)
2010 (27335)
Location
Africa (736)
Alabama (83)
Alaska (7)
Arizona (305)
Arkansas (13)
Asia (39191)
Australia (6405)
California (11161)
Canada (3252)
China (1085)
Colorado (471)
Connecticut (469)
Delaware (332)
Europe (84427)
Florida (1662)
Georgia (353)
Hawaii (3)
Idaho (61)
Illinois (852)
India (62)
Indiana (513)
Iowa (22)
Japan (418)
Kansas (125)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1369)
Massachusetts (7996)
Michigan (319)
Minnesota (622)
Mississippi (5)
Missouri (126)
Montana (31)
Nebraska (28)
Nevada (121)
New Hampshire (78)
New Jersey (2967)
New Mexico (28)
New York (2942)
North Carolina (1436)
North Dakota (8)
Northern California (5439)
Ohio (329)
Oklahoma (21)
Oregon (41)
Pennsylvania (2252)
Puerto Rico (22)
Rhode Island (47)
South America (1107)
South Carolina (65)
South Dakota (1)
Southern California (4344)
Tennessee (172)
Texas (1723)
United States (39566)
Utah (333)
Vermont (1)
Virginia (256)
Washington D.C. (81)
Washington State (913)
West Virginia (4)
Wisconsin (106)
Wyoming (2)
721,189 Results for "medeon biodesign inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Bio NC
Milestone® Pharmaceuticals Announces Data Presentations on Etripamil at Heart Rhythm 2024, 2024 Stanford BioDesign Arrhythmia Technologies Retreat, and ISPOR 2024
Milestone® Pharmaceuticals Inc. announced upcoming data presentations on etripamil at ISPOR 2024 being held in Atlanta, GA on May 5-8, 2024, the 2024 Stanford BioDesign Arrhythmia Technologies Retreat in Boston, MA, on May 15, 2024, and the Annual meeting of the Heart Rhythm Society, Heart Rhythm 2024, in Boston, MA on May 16-19, 2024.
May 2, 2024
·
1 min read
Sofinnova Partners Brings in Dr. Joshua Makower, Stanford Biodesign Co-Founder, as Venture Partner
Sofinnova Partners announced that Dr. Joshua Makower, co-founder and director of the Stanford Byers Center for Biodesign, has joined Sofinnova as an advisory Venture Partner.
January 4, 2024
·
3 min read
Press Releases
Qi Biodesign Completes $75 Million in Total Funding to Drive Genome Editing Innovations
December 9, 2024
·
2 min read
Deals
Vector Laboratories Acquires Quanta BioDesign to Continue Growth Strategy of Strengthening Development and Manufacturing Services for Life Science and Biopharma Customers
Vector Laboratories today announced the acquisition of Quanta BioDesign.
July 17, 2023
·
3 min read
Medeon Announces Positive Clinical Results for XFLO Minimally Invasive BPH Treatment Device
Medeon Biodesign, Inc., a Taiwan publicly traded medical device company, is pleased to announce positive interim results of the EXPANDER-1 Clinical Study for its flagship product the XFLO™ Expander System, an innovative, minimally invasive Benign Prostatic Hyperplasia treatment solution.
January 27, 2021
·
4 min read
Deals
Medeon Led and Completed Investments in Panther Orthopedics and Prodeon
Medeon Biodesign, Inc., a Taiwan publicly traded medical device company, is pleased to announce that it recently led and closed two investments, in Panther Orthopedics and Prodeon.
July 8, 2019
·
2 min read
Press Releases
Repare Announces Completion of Acquisition by XenoTherapeutics, Inc.
January 29, 2026
·
6 min read
Press Releases
Encision Inc. Announces Fiscal 2026 Third Quarter Results
February 4, 2026
·
1 min read
Press Releases
Therma Bright Inc. Investee Company, InStatin Expands its Inhaled Statin Programs to include COPD (Chronic Obstructive Pulmonary Disease) as its Lead Indication.
Includes Asthma in its strategic plans and Strengthens its Team in 2024-2025
December 18, 2025
·
5 min read
Press Releases
ABS Bio, Inc. acquires Cureline, Inc. to strengthen support of biopharma drug discovery
January 7, 2026
·
1 min read
1 of 72,119
Next
